Inactive Instrument
Synergy Pharmaceuticals Inc Stock Nasdaq
Stocks
US8716393082
Biotechnology & Medical Research
| 1 day | -52.00% |
| Manager | Title | Age | Since |
|---|---|---|---|
Leslie M. Magnus
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2015 |
Stephen Comiskey
PRN | Corporate Officer/Principal | - | 15/07/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -52.00% | -62.59% | - | - | 0 | |
| +1.44% | -1.25% | +63.52% | +114.88% | 54.44B | |
| +4.60% | +5.82% | +56.35% | +43.04% | 45.8B | |
| -1.44% | +1.51% | -12.94% | -19.24% | 22.98B | |
| -2.69% | -0.95% | -3.68% | +379.00% | 20.76B | |
| +3.22% | +2.94% | +24.02% | -35.05% | 16.25B | |
| +0.58% | +1.08% | +16.73% | -38.06% | 15.34B | |
| -1.01% | -2.97% | +27.42% | +171.92% | 13.05B | |
| +3.07% | +5.43% | +21.37% | - | 12.37B | |
| +4.95% | +13.49% | +121.11% | +249.05% | 12.47B | |
| Average | -3.93% | +2.19% | +34.88% | +108.19% | 23.72B | |
| Weighted average by Cap. | +1.63% | +1.38% | +39.56% | +98.70% |
Employees
-
